Drugs Approved for Leukemia
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in leukemia that are not listed here.
Drugs Approved for Acute Lymphoblastic Leukemia (ALL)
- Arranon (Nelarabine)
- Asparaginase Erwinia chrysanthemi
- Asparlas (Calaspargase Pegol-mknl)
- Besponsa (Inotuzumab Ozogamicin)
- Blinatumomab
- Blincyto (Blinatumomab)
- Calaspargase Pegol-mknl
- Cerubidine (Daunorubicin Hydrochloride)
- Clofarabine
- Clolar (Clofarabine)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Daunorubicin Hydrochloride
- Dexamethasone
- Doxorubicin Hydrochloride
- Erwinaze (Asparaginase Erwinia Chrysanthemi)
- Gleevec (Imatinib Mesylate)
- Iclusig (Ponatinib Hydrochloride)
- Inotuzumab Ozogamicin
- Imatinib Mesylate
- Kymriah (Tisagenlecleucel)
- Marqibo (Vincristine Sulfate Liposome)
- Mercaptopurine
- Methotrexate Sodium
- Nelarabine
- Oncaspar (Pegaspargase)
- Pegaspargase
- Ponatinib Hydrochloride
- Prednisone
- Purinethol (Mercaptopurine)
- Purixan (Mercaptopurine)
- Rubidomycin (Daunorubicin Hydrochloride)
- Sprycel (Dasatinib)
- Tisagenlecleucel
- Trexall (Methotrexate Sodium)
- Vincristine Sulfate
- Vincristine Sulfate Liposome
Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL)
Drugs Approved for Acute Myeloid Leukemia (AML)
- Arsenic Trioxide
- Azacitidine
- Cerubidine (Daunorubicin Hydrochloride)
- Cyclophosphamide
- Cytarabine
- Daunorubicin Hydrochloride
- Daunorubicin Hydrochloride and Cytarabine Liposome
- Daurismo (Glasdegib Maleate)
- Dexamethasone
- Doxorubicin Hydrochloride
- Enasidenib Mesylate
- Gemtuzumab Ozogamicin
- Gilteritinib Fumarate
- Glasdegib Maleate
- Idamycin PFS (Idarubicin Hydrochloride)
- Idarubicin Hydrochloride
- Idhifa (Enasidenib Mesylate)
- Ivosidenib
- Midostaurin
- Mitoxantrone Hydrochloride
- Mylotarg (Gemtuzumab Ozogamicin)
- Onureg (Azacitidine)
- Prednisone
- Rubidomycin (Daunorubicin Hydrochloride)
- Rydapt (Midostaurin)
- Tabloid (Thioguanine)
- Thioguanine
- Tibsovo (Ivosidenib)
- Trisenox (Arsenic Trioxide)
- Venclexta (Venetoclax)
- Venetoclax
- Vincristine Sulfate
- Vyxeos (Daunorubicin Hydrochloride and Cytarabine Liposome)
- Xospata (Gilteritinib Fumarate)
Drug Combinations Used in Acute Myeloid Leukemia (AML)
Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Drugs Approved for Chronic Lymphocytic Leukemia (CLL)
- Acalabrutinib
- Alemtuzumab
- Arzerra (Ofatumumab)
- Bendamustine Hydrochloride
- Bendeka (Bendamustine Hydrochloride)
- Calquence (Acalabrutinib)
- Campath (Alemtuzumab)
- Chlorambucil
- Copiktra (Duvelisib)
- Cyclophosphamide
- Dexamethasone
- Duvelisib
- Fludarabine Phosphate
- Gazyva (Obinutuzumab)
- Ibrutinib
- Idelalisib
- Imbruvica (Ibrutinib)
- Leukeran (Chlorambucil)
- Obinutuzumab
- Ofatumumab
- Prednisone
- Rituxan (Rituximab)
- Rituxan Hycela (Rituximab and Hyaluronidase Human)
- Rituximab
- Rituximab and Hyaluronidase Human
- Treanda (Bendamustine Hydrochloride)
- Truxima (Rituximab)
- Venclexta (Venetoclax)
- Venetoclax
- Zydelig (Idelalisib)
Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL)
Drugs Approved for Chronic Myelogenous Leukemia (CML)
- Bosulif (Bosutinib)
- Bosutinib
- Busulfan
- Busulfex (Busulfan)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Dexamethasone
- Gleevec (Imatinib Mesylate)
- Hydrea (Hydroxyurea)
- Hydroxyurea
- Iclusig (Ponatinib Hydrochloride)
- Imatinib Mesylate
- Myleran (Busulfan)
- Nilotinib
- Omacetaxine Mepesuccinate
- Ponatinib Hydrochloride
- Sprycel (Dasatinib)
- Synribo (Omacetaxine Mepesuccinate)
- Tasigna (Nilotinib)